Zobrazeno 1 - 10
of 31
pro vyhledávání: '"E. V. Papichev"'
Publikováno v:
Сибирский научный медицинский журнал, Vol 42, Iss 5, Pp 74-80 (2022)
Aim of the study was to investigate risk factors for osteoporosis (OP) in patients with rheumatoid arthritis (RA). Material and methods. We observed 110 patients with a verified diagnosis of RA. RA was diagnosed based on the 2010 EULAR/ACR clinical c
Externí odkaz:
https://doaj.org/article/29e53b0553724cdd9089909471434a13
Publikováno v:
Медицинский совет, Vol 0, Iss 2, Pp 114-126 (2022)
The limitation of the range of motion of the upper limb in combination with chronic pain syndrome and a decrease in the muscle strength of the arms leads to a significant deterioration in the quality of life of patients, often negatively affects thei
Externí odkaz:
https://doaj.org/article/6353a5eb01274766a733f37b3d735ce4
Publikováno v:
Медицинский совет, Vol 0, Iss 19, Pp 188-199 (2021)
For a long time, there has been scientific debate about the appropriateness of prescribing drugs to lower the level of uric acid in patients without clinical manifestations of gout. Long-term hyperuricemia is known to be the cause of gout and gouty a
Externí odkaz:
https://doaj.org/article/ac5ff702165a40df8997ab7f285727b0
Publikováno v:
Медицинский совет, Vol 0, Iss 19, Pp 170-176 (2021)
Introduction. Osteoporosis is a common complication of rheumatoid arthritis. Its development is associated with the mechanisms underlying in the progression of autoimmune inflammatory diseases and therapeutic approaches used for them. The study of ri
Externí odkaz:
https://doaj.org/article/dccb1850945d4650822efb1624d984fd
Publikováno v:
Медицинский совет, Vol 0, Iss 12, Pp 313-319 (2021)
The article presents clinical cases of management of patients with low compliance with treatment, suffering from rheumatic diseases and disorders of purine metabolism.Cases report 1. The first patient with advanced gout, after taking 100 mg of allopu
Externí odkaz:
https://doaj.org/article/68297d9f480249bd84137221842cc8c2
Publikováno v:
Сибирский научный медицинский журнал, Vol 41, Iss 4, Pp 66-72 (2021)
The aim of this work was to study the dependence of the concentration of C-reactive protein in the blood of patients on the severity of systemic lupus erythematosus (SLE). Material and methods. We examined 26 patients with SLE, the comparison group c
Externí odkaz:
https://doaj.org/article/79b343f95b844ec98afb4f3540f90848
Autor:
E. V. Papichev, B. V. Zavodovsky, L. E. Sivordova, Yu. R. Akhverdyan, Yu. V. Polyakova, I. A. Zborovskaya
Publikováno v:
Сибирский научный медицинский журнал, Vol 40, Iss 5, Pp 92-97 (2020)
Background. Rheumatoid cachexia is a pathological condition which appears in patients with rheumatoid arthritis with low fat-free mass and normal or high body mass index. Bone mass loss is one of the components of rheumatoid cachexia. Fetuin-A, a maj
Externí odkaz:
https://doaj.org/article/62b51aa644844ab0b90bacb113c4f7a5
Publikováno v:
Travmatologiâ i Ortopediâ Rossii, Vol 26, Iss 2, Pp 120-127 (2020)
Objective. To compare the efficacy and tolerability of long-term and short-term continuous NSAIDs in patients with knee osteoarthritis with insufficient efficacy “on demand” NSAIDs and SYSADOA.Study design. 12-week, prospective, comparative, rand
Externí odkaz:
https://doaj.org/article/055fd0b190f94542b70f8ce7a8b4892d
Publikováno v:
Терапевтический архив, Vol 92, Iss 5, Pp 61-68 (2020)
Aim. To evaluate the effectiveness and tolerability of the drug in patients with undifferentiated peripheral inflammatory arthritis (UPIA). Materials and methods. We observed 60 patients (39 women and 21 men) met G. Hazlewood et al., UPIA criteria,
Externí odkaz:
https://doaj.org/article/96fe93230cf142888c21757d327fceec
Autor:
V. N. Amirdzhanova, E. Yu. Pogozheva, A. E. Karateev, O. V. Antipova, I. B. Vinogradova, A. Yu. Kazankova, R. G. Mukhina, A. G. Vasilyev, O. B. Nesmeyanova, E. A. Bogdanova, R. R. Samigullina, A. A. Vasilenko, I. B. Bashkova, T. S. Salnikova, I. N. Dashkov, N. E. Nikulenkova, V. Yu. Manokhin, I. P. Afanasyeva, O. N. Anoshenkova, T. V. Plaksina, M. R. Spitsina, L. V. Solodovnikova, A. V. Petrov, O. P. Slyusar, E. V. Papichev, E. V. Ivanova, L. V. Masneva, L. P. Evstigneeva, I. V. Kolotilina, E. N. Otteva, I. A. Cherentsova, I. N. Shchendrygin, S. A. Derevenskikh, I. G. Bannikova, N. K. Delyavskaya, I. N. Danilova, I. M. Marusenko
Publikováno v:
Современная ревматология, Vol 13, Iss 3, Pp 30-38 (2019)
Objective: to assess quality-of-life (QoL) dynamics in patients with rheumatoid arthritis (RA) when initiating therapy with biological agents (BAs) in real clinical practice.Patients and methods. The investigation enrolled patients with RA from the p
Externí odkaz:
https://doaj.org/article/3606913e2b6f4d75804f536e5a45b4e7